Literature DB >> 1311926

A new type of hepatitis C virus in patients in Thailand.

S Mori1, N Kato, A Yagyu, T Tanaka, Y Ikeda, B Petchclai, P Chiewsilp, T Kurimura, K Shimotohno.   

Abstract

Partial nucleotide sequences in the tentative NS5 region of the hepatitis C viral genome obtained from patients with chronic hepatitis in Thailand were analyzed by reverse transcription followed by the polymerase chain reaction. Of ten samples studied, four showed low homologies to any known type of HCV: the homologies of the nucleotide sequences of these clones with HCV-J, -US, -K2a and -K2b were 66.5-69.1%, 66.5-68.2%, 61.2-64.1% and 64.4-66.2%, respectively, and the homologies of their deduced amino acids sequences were 71.7-75.2%, 71.7-75.2%, 69.0-72.6% and 69.9-73.5%, respectively. These four clones were classified a new distinct type of HCV, named HCV-T. Moreover, the nucleotide and amino acid sequence homologies of the four HCV-T clones showed that the HCV-T type could be classified into two genotypes, HCV-Ta and HCV-Tb.

Entities:  

Mesh:

Year:  1992        PMID: 1311926     DOI: 10.1016/0006-291x(92)91648-a

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

1.  Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypes.

Authors:  L Krekulova; V Rehak; A E Wakil; E Harris; L W Riley
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes.

Authors:  L Stuyver; W van Arnhem; A Wyseur; F Hernandez; E Delaporte; G Maertens
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

3.  Genotypic distribution of hepatitis C virus in different regions of Thailand.

Authors:  D Kanistanon; M Neelamek; T Dharakul; S Songsivilai
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

4.  Structure of the 3' terminus of the hepatitis C virus genome.

Authors:  T Tanaka; N Kato; M J Cho; K Sugiyama; K Shimotohno
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

6.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.

Authors:  N Kato; H Sekiya; Y Ootsuyama; T Nakazawa; M Hijikata; S Ohkoshi; K Shimotohno
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Analysis of the core and E1 envelope region sequences of a novel variant of hepatitis C virus obtained in Indonesia.

Authors:  H Hotta; H Doi; T Hayashi; M Purwanta; W Soemarto; M Mizokami; K Ohba; M Homma
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.

Authors:  R Nagayama; F Tsuda; H Okamoto; Y Wang; T Mitsui; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

9.  At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

10.  Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups.

Authors:  H Tokita; H Okamoto; F Tsuda; P Song; S Nakata; T Chosa; H Iizuka; S Mishiro; Y Miyakawa; M Mayumi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.